{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T20:19:06Z","timestamp":1770409146818,"version":"3.49.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["Fonds De La Recherche Scientifique - FNRS"],"award-info":[{"award-number":["Fonds De La Recherche Scientifique - FNRS"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020049","name":"Brugmann Foundation","doi-asserted-by":"publisher","award":["Brugmann Foundation"],"award-info":[{"award-number":["Brugmann Foundation"]}],"id":[{"id":"10.13039\/501100020049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00213-025-06855-2","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T02:11:06Z","timestamp":1752891066000},"page":"211-223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of anti-craving medication on cue reactivity and abstinence in patients undergoing alcohol detoxification: some preliminary evidence from a retrospective event-related potentials study"],"prefix":"10.1007","volume":"243","author":[{"given":"Cl\u00e9mence","family":"Dousset","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Sistiaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana\u00efs","family":"Ingels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Hanak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Kajosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7331-5906","authenticated-orcid":false,"given":"Salvatore","family":"Campanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"issue":"5","key":"6855_CR1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/alcalc\/37.5.504","volume":"37","author":"G Addolorato","year":"2002","unstructured":"Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, Agabio R, Colombo G, Gessa GL, Gasbarrini G (2002) Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol 37(5):504\u2013508","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"6855_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/alcalc\/agr017","volume":"46","author":"G Addolorato","year":"2011","unstructured":"Addolorato G, Leggio L, Ferrulli A, Cardone S, Bedogni G, Caputo F, Gasbarrini G, Landolfi R (2011) Dose-response effect of Baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol 46(3):312\u2013317","journal-title":"Alcohol Alcohol"},{"key":"6855_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pharmthera.2017.11.007","volume":"185","author":"M Akbar","year":"2018","unstructured":"Akbar M, Egli M, Cho YE, Song BJ, Noronha A (2018) Medications for alcohol use disorders: an overview. Pharmacol Ther 185:64\u201385","journal-title":"Pharmacol Ther"},{"key":"6855_CR4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. Author, Washington, DC","edition":"5"},{"key":"6855_CR5","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","volume":"295","author":"RF Anton","year":"2006","unstructured":"Anton RF, O\u2019Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM et al (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence. The combine study: a randomized controlled trial. JAMA 295:2003\u20132017","journal-title":"JAMA"},{"issue":"2","key":"6855_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1001\/archpsyc.65.2.135","volume":"65","author":"RF Anton","year":"2008","unstructured":"Anton RF, Oroszi G, O\u2019Malley S, Couper D, Swift R, Pettinati H, Goldman D (2008) An evaluation of \u00b5-opioid receptor (OPRM1) as a predictor of Naltrexone response in the treatment of alcohol dependence: results from the combined pharmacotherapies and behavioral interventions for alcohol dependence (COMBINE) study. Arch Gen Psychiatry 65(2):135\u2013144","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"6855_CR7","first-page":"490","volume":"78","author":"AT Beck","year":"1996","unstructured":"Beck AT, Steer RA, Brown GK (1996) Beck depression inventory-II. San Antonio 78(2):490\u2013498","journal-title":"San Antonio"},{"key":"6855_CR8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/archgenpsychiatry.2011.2026","volume":"69","author":"A Beck","year":"2012","unstructured":"Beck A, Wustenberg T, Genauck A, Wrase J, Schlagenhauf F, Smolka MN, Mann K, Heinz A (2012) Effect of brain structure, brain function, and brain connectivity on relapse in alcohol-dependent patients. Arch Gen Psychiatry 69:842\u2013852","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"6855_CR9","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.euroneuro.2018.08.507","volume":"28","author":"A Beck","year":"2018","unstructured":"Beck A, Pelz P, Lorenz RC, Charlet K, Geisel O, Heinz A, M\u00fcller CA (2018) Effects of high-dose Baclofen on cue reactivity in alcohol dependence: a randomized, placebo-controlled pharmaco-fMRI study. Eur Neuropsychopharmacol 28(11):1206\u20131216","journal-title":"Eur Neuropsychopharmacol"},{"issue":"12","key":"6855_CR10","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1016\/j.euroneuro.2016.10.006","volume":"26","author":"EM Beraha","year":"2016","unstructured":"Beraha EM, Salemink E, Goudriaan AE, Bakker A, de Jong D, Smits N, Wiers RW (2016) Efficacy and safety of high-dose Baclofen for the treatment of alcohol dependence: a multicentre, randomised, double-blind controlled trial. Eur Neuropsychopharmacol 26(12):1950\u20131959","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"6855_CR11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.clinph.2019.10.020","volume":"131","author":"S Campanella","year":"2020","unstructured":"Campanella S, Schroder E, Kajosch H, Hanak C, Veeser J, Amiot M, Kornreich C (2020) Neurophysiological markers of cue reactivity and Inhibition subtend a three-month period of complete alcohol abstinence. Clin Neurophysiol 131(2):555\u2013565","journal-title":"Clin Neurophysiol"},{"issue":"5","key":"6855_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5498\/wjp.v11.i5.153","volume":"11","author":"S Campanella","year":"2021","unstructured":"Campanella S (2021) Use of cognitive event-related potentials in the management of psychiatric disorders: towards an individual follow-up and multi-component clinical approach. World J Psychiatry 11(5):153","journal-title":"World J Psychiatry"},{"issue":"11","key":"6855_CR13","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/j.clinph.2010.04.004","volume":"121","author":"S Campanella","year":"2010","unstructured":"Campanella S, Bruyer R, Froidbise S, Rossignol M, Joassin F, Kornreich C et al (2010) Is two better than one? A cross-modal oddball paradigm reveals greater sensitivity of the P300 to emotional face-voice associations. Clin Neurophysiol 121(11):1855\u20131862","journal-title":"Clin Neurophysiol"},{"issue":"5","key":"6855_CR14","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.clinph.2011.10.041","volume":"123","author":"S Campanella","year":"2012","unstructured":"Campanella S, Delle-Vigne D, Kornreich C, Verbanck P (2012) Greater sensitivity of the P300 component to bimodal stimulation in an event-related potentials oddball task. Clin Neurophysiol 123(5):937\u2013946","journal-title":"Clin Neurophysiol"},{"key":"6855_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neubiorev.2018.06.016","volume":"106","author":"S Campanella","year":"2019","unstructured":"Campanella S, Schroder E, Kajosch H, Noel X, Kornreich C (2019) Why cognitive event-related potentials (ERPs) should have a role in the management of alcohol disorders. Neurosci Biobehavioral Reviews 106:234\u2013244","journal-title":"Neurosci Biobehavioral Reviews"},{"issue":"2","key":"6855_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1037\/0022-3514.67.2.319","volume":"67","author":"CS Carver","year":"1994","unstructured":"Carver CS, White TL (1994) Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: the BIS\/BAS scales. J Personal Soc Psychol 67(2):319","journal-title":"J Personal Soc Psychol"},{"issue":"2","key":"6855_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/alcalc\/35.2.176","volume":"35","author":"J Chick","year":"2000","unstructured":"Chick J, Howlett H, Morgan MY, Ritson B (2000) United Kingdom multicentre acamprosate study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol Alcohol 35(2):176\u2013187","journal-title":"Alcohol Alcohol"},{"issue":"2","key":"6855_CR18","doi-asserted-by":"publisher","first-page":"13967","DOI":"10.1111\/psyp.13967","volume":"59","author":"RU Cofres\u00ed","year":"2022","unstructured":"Cofres\u00ed RU, Piasecki TM, Hajcak G, Bartholow BD (2022) Internal consistency and test\u2013retest reliability of the P3 event-related potential (ERP) elicited by alcoholic and non\u2010alcoholic beverage pictures. Psychophysiology 59(2):13967","journal-title":"Psychophysiology"},{"issue":"1","key":"6855_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/adb.12314","volume":"21","author":"KE Courtney","year":"2016","unstructured":"Courtney KE, Schacht JP, Hutchison K, Roche DJ, Ray LA (2016) Neural substrates of cue reactivity: association with treatment outcomes and relapse. Addict Biol 21(1):3\u201322","journal-title":"Addict Biol"},{"issue":"1\u20132","key":"6855_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0376-8716(98)00186-0","volume":"55","author":"WM Cox","year":"1999","unstructured":"Cox WM, Yeates GN, Regan CM (1999) Effects of alcohol cues on cognitive processing in heavy and light drinkers. Drug Alcohol Depend 55(1\u20132):85\u201389","journal-title":"Drug Alcohol Depend"},{"key":"6855_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3389\/fpsyt.2018.00506","volume":"9","author":"R De Beaurepaire","year":"2018","unstructured":"De Beaurepaire R (2018) A review of the potential mechanisms of action of Baclofen in alcohol use disorder. Front Psychiatry 9:506","journal-title":"Front Psychiatry"},{"key":"6855_CR22","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3389\/fpsyt.2018.00708","volume":"9","author":"R De Beaurepaire","year":"2019","unstructured":"De Beaurepaire R, Sinclair JM, Heydtmann M, Addolorato G, Aubin HJ, Beraha EM, Agabio R (2019) The use of Baclofen as a treatment for alcohol use disorder: a clinical practice perspective. Front Psychiatry 9:708","journal-title":"Front Psychiatry"},{"issue":"6","key":"6855_CR23","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.brs.2021.10.386","volume":"14","author":"M Dubuson","year":"2021","unstructured":"Dubuson M, Kornreich C, Vanderhasselt MA, Baeken C, Wyckmans F, Dousset C, No\u00ebl X (2021) Transcranial direct current stimulation combined with alcohol cue inhibitory control training reduces the risk of early alcohol relapse: a randomized placebo-controlled clinical trial. Brain Stimul 14(6):1531\u20131543","journal-title":"Brain Stimul"},{"key":"6855_CR24","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1046\/j.1360-0443.1996.911217733.x","volume":"91","author":"JW Finney","year":"1996","unstructured":"Finney JW, Hahn AC, Moos RH (1996) The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects. Addiction 91:1773\u20131796","journal-title":"Addiction"},{"key":"6855_CR25","doi-asserted-by":"crossref","unstructured":"Flaudias V, Brousse G, de Chazeron I, Planche F, Brun J, Llorca PM (2013) Treatment in hospital for alcohol-dependent patients decreases attentional bias. Neuropsychiatr Dis Treat 773\u2013779","DOI":"10.2147\/NDT.S42556"},{"issue":"11","key":"6855_CR26","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/j.1530-0277.2010.01273.x","volume":"34","author":"JC Garbutt","year":"2010","unstructured":"Garbutt JC, Kampov-Polevoy AB, Gallop R, Kalka-Juhl L, Flannery BA (2010) Efficacy and safety of Baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcoholism Clin Experimental Res 34(11):1849\u20131857","journal-title":"Alcoholism Clin Experimental Res"},{"key":"6855_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s00213-004-1828-4","volume":"175","author":"SM Gr\u00fcsser","year":"2004","unstructured":"Gr\u00fcsser SM, Wrase J, Klein S, Hermann D, Smolka MN, Ruf M, Weber-Fahr W, Flor H, Mann K, Braus DF, Heinz A (2004) Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology 175:296\u2013302","journal-title":"Psychopharmacology"},{"key":"6855_CR28","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1007\/978-3-030-62059-2_430","volume-title":"NeuroPsychopharmacotherapy","author":"R Guglielmo","year":"2022","unstructured":"Guglielmo R, Kobylinska L, de Filippis R (2022) Topiramate, naltrexone, and acamprosate in the treatment of alcohol use disorders. NeuroPsychopharmacotherapy. Springer International Publishing, Cham, pp 2535\u20132550"},{"key":"6855_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00213-009-1515-6","volume":"205","author":"A Hammarberg","year":"2009","unstructured":"Hammarberg A, Jayaram-Lindstr\u00f6m N, Beck O, Franck J, Reid MS (2009) The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial. Psychopharmacology 205:53\u201362","journal-title":"Psychopharmacology"},{"issue":"4","key":"6855_CR30","first-page":"241","volume":"39","author":"C Hanak","year":"2018","unstructured":"Hanak C (2018) Prise En charge du sevrage alcoolique. Rev Med Bruxelles 39(4):241\u2013245","journal-title":"Rev Med Bruxelles"},{"issue":"11","key":"6855_CR31","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1097\/01.ALC.0000093601.33119.E3","volume":"27","author":"BR Harris","year":"2003","unstructured":"Harris BR, Gibson DA, Prendergast MA, Blanchard JA, Holley RC, Hart SR, Littleton JM (2003) The neurotoxicity induced by ethanol withdrawal in mature organotypic hippocampal slices might involve cross-talk between metabotropic glutamate type 5 receptors and N\u2010methyl\u2010D\u2010aspartate receptors. Alcoholism: Clin Experimental Res 27(11):1724\u20131735","journal-title":"Alcoholism: Clin Experimental Res"},{"issue":"1","key":"6855_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1037\/a0017895","volume":"24","author":"A Hogue","year":"2010","unstructured":"Hogue A, Dauber S, Morgenstern J (2010) Validation of a contemplation ladder in an adult substance use disorder sample. Psychol Addict Behav 24(1):137","journal-title":"Psychol Addict Behav"},{"issue":"6","key":"6855_CR33","doi-asserted-by":"publisher","first-page":"772","DOI":"10.26502\/acmcr.96550561","volume":"6","author":"A Ingels","year":"2022","unstructured":"Ingels A, Fabry L, Hanak C, Hanard F, Kajosch H, Kornreich C, Campanella S (2022) Using cognitive event-related potentials in the management of alcohol use disorder: towards an individual approach. Archives Clin Med Case Rep 6(6):772\u2013775","journal-title":"Archives Clin Med Case Rep"},{"issue":"1","key":"6855_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bcp.2007.08.005","volume":"75","author":"BA Johnson","year":"2008","unstructured":"Johnson BA (2008) Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem Pharmacol 75(1):34\u201356","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"6855_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.15288\/jsa.1985.46.267","volume":"46","author":"RF Kaplan","year":"1985","unstructured":"Kaplan RF, Cooney NL, Baker LH, Gillespie RA, Meyer RE, Pomerleau OF (1985) Reactivity to alcohol-related cues: physiological and subjective responses in alcoholics and nonproblem drinkers. J Stud Alcohol 46(4):267\u2013272","journal-title":"J Stud Alcohol"},{"key":"6855_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00213-003-1441-y","volume":"168","author":"JL Katz","year":"2003","unstructured":"Katz JL, Higgins ST (2003) The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology 168:21\u201330","journal-title":"Psychopharmacology"},{"key":"6855_CR37","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.addbeh.2012.08.004","volume":"38","author":"DJ Kavanagh","year":"2013","unstructured":"Kavanagh DJ, Statham DJ, Feeney GFX, Young RM, May J, Andrade J, Connor JP (2013) Measurement of alcohol craving. Addict Behav 38:1572\u20131584","journal-title":"Addict Behav"},{"key":"6855_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2174\/1874473710902020135","volume":"2","author":"GA Kenna","year":"2009","unstructured":"Kenna GA, Lomastro TL, Schiesl A, Leggio L, Swift RM (2009) Review of topiramate: an antiepileptic for the treatment of alcohol dependence. Curr Drug Abuse Rev 2:135\u2013142","journal-title":"Curr Drug Abuse Rev"},{"issue":"1","key":"6855_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","volume":"60","author":"F Kiefer","year":"2003","unstructured":"Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, Wiedemann K (2003) Comparing and combining Naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 60(1):92\u201399","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"6855_CR40","doi-asserted-by":"publisher","first-page":"e13368","DOI":"10.1111\/adb.13368","volume":"29","author":"CB Kohen","year":"2024","unstructured":"Kohen CB, Cofres\u00ed RU, Piasecki TM, Bartholow BD (2024) Predictive utility of the P3 event-related potential (ERP) response to alcohol cues for ecologically assessed alcohol craving and use. Addict Biol 29(2):e13368. https:\/\/doi.org\/10.1111\/adb.13368","journal-title":"Addict Biol"},{"issue":"24","key":"6855_CR41","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMoa011127","volume":"345","author":"JH Krystal","year":"2001","unstructured":"Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA (2001) Naltrexone in the treatment of alcohol dependence. N Engl J Med 345(24):1734\u20131739","journal-title":"N Engl J Med"},{"issue":"5","key":"6855_CR42","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/JCP.0b013e318267b586","volume":"32","author":"JM Langosch","year":"2012","unstructured":"Langosch JM, Spiegelhalder K, Jahnke K, Feige B, Regen W, Kiemen A, Olbrich HM (2012) The impact of acamprosate on cue reactivity in alcohol dependent individuals: a functional magnetic resonance imaging study. J Clin Psychopharmacol 32(5):661\u2013665","journal-title":"J Clin Psychopharmacol"},{"key":"6855_CR43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00213-014-3652-9","volume":"232","author":"L Leggio","year":"2015","unstructured":"Leggio L, Zywiak WH, Edwards SM, Tidey JW, Swift RM, Kenna GA (2015) A preliminary double-blind, placebo-controlled randomized study of Baclofen effects in alcoholic smokers. Psychopharmacology 232:233\u2013243","journal-title":"Psychopharmacology"},{"issue":"7","key":"6855_CR44","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3109\/15622975.2013.812239","volume":"14","author":"M Lieb","year":"2013","unstructured":"Lieb M, Palm U, Chiang S, Laubender RP, Nothdurfter C, Sarubin N, Soyka M (2013) Pharmacological challenge with Naloxone and cue exposure in alcohol dependence: results of a randomized, double-blind placebo-controlled trial. World J Biol Psychiatry 14(7):539\u2013546","journal-title":"World J Biol Psychiatry"},{"issue":"8","key":"6855_CR45","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.neubiorev.2012.05.001","volume":"36","author":"M Littel","year":"2012","unstructured":"Littel M, Euser AS, Munaf\u00f2 MR, Franken IHA (2012) Electrophysiological indices of biased cognitive processing of substance-related cues: a meta-analysis. Neurosci Biobehav Rev 36(8):1803\u20131816","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"6855_CR46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","volume":"108","author":"NC Maisel","year":"2013","unstructured":"Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW (2013) Meta-analysis of Naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction 108(2):275\u2013293","journal-title":"Addiction"},{"key":"6855_CR47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s00406-010-0153-7","volume":"260","author":"K Mann","year":"2010","unstructured":"Mann K, Hermann D (2010) Individualised treatment in alcohol-dependent patients. Eur Arch Psychiatry Clin NeuroSci 260:116\u2013120","journal-title":"Eur Arch Psychiatry Clin NeuroSci"},{"issue":"2","key":"6855_CR48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1001\/jamapsychiatry.2020.3446","volume":"78","author":"V Manning","year":"2021","unstructured":"Manning V, Garfield JB, Staiger PK, Lubman DI, Lum JA, Reynolds J, Verdejo-Garcia A (2021) Effect of cognitive bias modification on early relapse among adults undergoing inpatient alcohol withdrawal treatment: a randomized clinical trial. JAMA Psychiatry 78(2):133\u2013140","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"6855_CR49","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3390\/brainsci13081206","volume":"13","author":"MCD Marin","year":"2023","unstructured":"Marin MCD, Pedro MOP, Perrotte G, Martins-da-Silva AS, Lassi DL, Blaas IK, Castaldelli-Maia JM (2023) Pharmacological treatment of alcohol cravings. Brain Sci 13(8):1206","journal-title":"Brain Sci"},{"issue":"5","key":"6855_CR50","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/adb.12050","volume":"19","author":"R Miranda","year":"2014","unstructured":"Miranda R, Ray L, Blanchard A, Reynolds EK, Monti PM, Chun T, Ramirez J (2014) Effects of Naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial. Addict Biol 19(5):941\u2013954","journal-title":"Addict Biol"},{"issue":"7","key":"6855_CR51","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/acer.14352","volume":"44","author":"R Miranda Jr","year":"2020","unstructured":"Miranda Jr R, O\u2019Malley SS, Padovano T, Wu H, Falk R, Ryan DE, Litten ML, R. Z (2020) Effects of alcohol cue reactivity on subsequent treatment outcomes among treatment-seeking individuals with alcohol use disorder: a multisite randomized, double\u2010blind, placebo\u2010controlled clinical trial of varenicline. Alcoholism: Clin Experimental Res 44(7):1431\u20131443","journal-title":"Alcoholism: Clin Experimental Res"},{"issue":"10","key":"6855_CR52","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/j.1360-0443.2006.01555.x","volume":"101","author":"KC Morley","year":"2006","unstructured":"Morley KC, Teesson M, Reid SC, Sannibale C, Thomson C, Phung N et al (2006) Naltrexone versus acamprosate in the treatment of alcohol dependence: a multicentre, randomized, double-blind, placebo-controlled trial. Addiction 101(10):1451\u20131462","journal-title":"Addiction"},{"issue":"6","key":"6855_CR53","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1192\/bjp.2018.13","volume":"212","author":"KC Morley","year":"2018","unstructured":"Morley KC, Baillie A, Fraser I, Furneaux-Bate A, Dore G, Roberts M, Haber PS (2018) Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial. Br J Psychiatry 212(6):362\u2013369","journal-title":"Br J Psychiatry"},{"key":"6855_CR54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.euroneuro.2021.02.010","volume":"46","author":"KC Morley","year":"2021","unstructured":"Morley KC, Logge WB, Fraser I, Morris RW, Baillie AJ, Haber PS (2021) High-dose Baclofen attenuates Insula activation during anticipatory anxiety in treatment-seeking alcohol dependant individuals: preliminary findings from a pharmaco-fMRI study. Eur Neuropsychopharmacol 46:28\u201336","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"6855_CR55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/alcalc\/agg038","volume":"38","author":"K Namkoong","year":"2003","unstructured":"Namkoong K, Lee BO, Lee PG, Choi MJ, Lee E (2003) Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study. Alcohol Alcohol 38(2):135\u2013141","journal-title":"Alcohol Alcohol"},{"key":"6855_CR56","first-page":"141a","volume-title":"alcoholism-clinical and experimental research","author":"W Ooteman","year":"2006","unstructured":"Ooteman W (2006) Predicting the effect of Naltrexone and acamprosate in alcohol-dependent patients using phenotypic, endophenotypic and genetic indicators. alcoholism-clinical and experimental research, vol 30. Blackwell Publishing, Oxford, England, pp 141a\u2013141a. 9"},{"issue":"8","key":"6855_CR57","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.euroneuro.2007.02.012","volume":"17","author":"W Ooteman","year":"2007","unstructured":"Ooteman W, Koeter MW, Verheul R, Schippers GM, van den Brink W (2007) The effect of Naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics. Eur Neuropsychopharmacol 17(8):558\u2013566","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"6855_CR58","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/add.13974","volume":"113","author":"C Palpacuer","year":"2018","unstructured":"Palpacuer C, Duprez R, Huneau A, Locher C, Boussageon R, Laviolle B, Naudet F (2018) Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, Baclofen and topiramate. Addiction 113(2):220\u2013237","journal-title":"Addiction"},{"issue":"2","key":"6855_CR59","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/dar.13568","volume":"42","author":"M Pepe","year":"2023","unstructured":"Pepe M, Di Nicola M, Panaccione I, Franza R, De Berardis D, Cibin M, Sani G (2023) Impulsivity and alexithymia predict early versus subsequent relapse in patients with alcohol use disorder: a 1-year longitudinal study. Drug Alcohol Rev 42(2):367\u2013372","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"6855_CR60","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.psychres.2013.04.005","volume":"209","author":"G Petit","year":"2013","unstructured":"Petit G, Kornreich C, Verbanck P, Campanella S (2013) Gender differences in reactivity to alcohol cues in binge drinkers: a preliminary assessment of event-related potentials. Psychiatry Res 209(3):494\u2013503","journal-title":"Psychiatry Res"},{"key":"6855_CR61","first-page":"1025","volume":"10","author":"G Petit","year":"2014","unstructured":"Petit G, Cimochowska A, Kornreich C, Hanak C, Verbanck P, Campanella S (2014) Neurophysiological correlates of response Inhibition predict relapse in detoxified alcoholic patients: some preliminary evidence from event-related potentials. Neuropsychiatric Dis Treat 10:1025\u20131037","journal-title":"Neuropsychiatric Dis Treat"},{"key":"6855_CR62","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbr.2014.12.057","volume":"282","author":"G Petit","year":"2015","unstructured":"Petit G, Cimochowska A, Cevallos C, Cheron G, Kornreich C, Hanak C, Campanella S (2015) Reduced processing of alcohol cues predicts abstinence in recently detoxified alcoholic patients in a three-month follow up period: an ERP study. Behav Brain Res 282:84\u201394","journal-title":"Behav Brain Res"},{"issue":"9590","key":"6855_CR63","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0140-6736(07)61238-0","volume":"370","author":"M Prince","year":"2007","unstructured":"Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, Rahman A (2007) No health without mental health. Lancet 370(9590):859\u2013877","journal-title":"Lancet"},{"issue":"1","key":"6855_CR64","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1360-0443.2001.9611038.x","volume":"96","author":"TE Robinson","year":"2001","unstructured":"Robinson TE, Berridge KC (2001) Incentive-sensitization and addiction. Addiction 96(1):103\u2013114","journal-title":"Addiction"},{"issue":"9","key":"6855_CR65","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.clinph.2020.06.012","volume":"131","author":"KB Rohde","year":"2020","unstructured":"Rohde KB, Fey W, Moggi F, Koenig T, Luedi I, Duppenthaler L, Stein M (2020) Deficient processing of alcohol cues in the addicted brain: evidence from event-related potential microstates. Clin Neurophysiol 131(9):2224\u20132235","journal-title":"Clin Neurophysiol"},{"key":"6855_CR66","first-page":"225","volume":"23","author":"DJ Rohsenow","year":"1999","unstructured":"Rohsenow DJ, Monti PM (1999) Does urge to drink predict relapse after treatment? Alcohol Res Health 23:225\u2013232","journal-title":"Alcohol Res Health"},{"key":"6855_CR67","doi-asserted-by":"publisher","first-page":"205031212110221","DOI":"10.1177\/20503121211022197","volume":"9","author":"JW Romito","year":"2021","unstructured":"Romito JW, Turner ER, Rosener JA, Coldiron L, Udipi A, Nohrn L, Romito BT (2021) Baclofen therapeutics, toxicity, and withdrawal: a narrative review. SAGE Open Med 9:20503121211022197","journal-title":"SAGE Open Med"},{"issue":"1","key":"6855_CR68","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/0269881107078308","volume":"22","author":"S R\u00f6sner","year":"2008","unstructured":"R\u00f6sner S, Leucht S, Lehert P, Soyka M (2008) Acamprosate supports abstinence, Naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes. J Psychopharmacol 22(1):11\u201323","journal-title":"J Psychopharmacol"},{"issue":"5","key":"6855_CR69","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/alcalc\/36.5.419","volume":"36","author":"G Rubio","year":"2001","unstructured":"Rubio G, Jim\u00e9nez-Arriero MA, Ponce G, Palomo T (2001) Naltrexone versus acamprosate: 1-year follow-up of alcohol dependence treatment. Alcohol Alcohol 36(5):419\u2013425","journal-title":"Alcohol Alcohol"},{"key":"6855_CR70","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993) Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol Consumption\u2013II. Addiction 88:791\u2013804","journal-title":"Addiction"},{"issue":"1","key":"6855_CR71","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1369-1600.2012.00464.x","volume":"18","author":"JP Schacht","year":"2013","unstructured":"Schacht JP, Anton RF, Myrick H (2013) Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addict Biol 18(1):121\u2013133","journal-title":"Addict Biol"},{"key":"6855_CR72","volume-title":"Alcohol craving questionnaire, Short-Form (Revised)(ACQ-SF-R). Background, scoring, and administration. Investigaci\u00f3n no publicada, behavioral Pharmacology research unit (BPRU), department of psychiatry and behavioral sciences","author":"EG Singleton","year":"1995","unstructured":"Singleton EG (1995) Alcohol craving questionnaire, Short-Form (Revised)(ACQ-SF-R). Background, scoring, and administration. Investigaci\u00f3n no publicada, behavioral Pharmacology research unit (BPRU), department of psychiatry and behavioral sciences. The Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"issue":"5","key":"6855_CR73","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/npp.2008.78","volume":"34","author":"R Sinha","year":"2009","unstructured":"Sinha R, Fox HC, Hong KA, Bergquist K, Bhagwagar Z, Siedlarz KM (2009) Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 34(5):1198\u20131208","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"6855_CR74","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1080\/10826084.2017.1399420","volume":"53","author":"M Snelleman","year":"2018","unstructured":"Snelleman M, Schoenmakers TM, van de Mheen D (2018) Relapse and craving in alcohol-dependent individuals: a comparison of self-reported determinants. Subst Use Misuse 53(7):1099\u20131107","journal-title":"Subst Use Misuse"},{"issue":"4","key":"6855_CR75","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/00952990802082198","volume":"34","author":"JL Snyder","year":"2008","unstructured":"Snyder JL, Bowers TG (2008) The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials. The American journal of drug and alcohol abuse 34(4):449\u2013461","journal-title":"The American journal of drug and alcohol abuse"},{"issue":"4","key":"6855_CR76","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/npp.2013.264","volume":"39","author":"R Spanagel","year":"2014","unstructured":"Spanagel R, Vengeliene V, Jandeleit B, Fischer WN, Grindstaff K, Zhang X, Kiefer F (2014) Acamprosate produces its anti-relapse effects via calcium. Neuropsychopharmacology 39(4):783\u2013791","journal-title":"Neuropsychopharmacology"},{"key":"6855_CR77","volume-title":"Manual for the State-Trait anxiety inventory (STAI)","author":"CD Spielberger","year":"1983","unstructured":"Spielberger CD (1983) Manual for the State-Trait anxiety inventory (STAI). Consulting Psychologists, Palo Alto, CA"},{"issue":"1","key":"6855_CR78","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0306-4603(98)00029-X","volume":"24","author":"RL Stout","year":"1999","unstructured":"Stout RL, Rubin A, Zwick W, Zywiak W, Bellino L (1999) Optimizing the cost-effectiveness of alcohol treatment: A rationale for extended case monitoring. Addict Behav 24(1):17\u201335","journal-title":"Addict Behav"},{"issue":"1","key":"6855_CR79","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.addbeh.2003.07.003","volume":"29","author":"SF Tapert","year":"2004","unstructured":"Tapert SF, Brown GG, Baratta MV, Brown SA (2004) fMRI BOLD response to alcohol stimuli in alcohol dependent young women. Addict Behav 29(1):33\u201350","journal-title":"Addict Behav"},{"key":"6855_CR80","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1037\/0033-295X.97.2.147","volume":"97","author":"ST Tiffany","year":"1990","unstructured":"Tiffany ST (1990) A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychol Rev 97:147\u2013168","journal-title":"Psychol Rev"},{"key":"6855_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06298.x","volume":"1248","author":"ST Tiffany","year":"2012","unstructured":"Tiffany ST, Wray JM (2012) The clinical significance of drug craving. Ann N Y Acad Sci 1248:1\u201317","journal-title":"Ann N Y Acad Sci"},{"key":"6855_CR82","unstructured":"Tyson LD, Cheng A, Kelleher C, Strathie K, Lovendoski J, Habtemariam Z, Lewis H (2021) Acamprosate for the treatment of alcohol use disorder may be safer than baclofen in patients with cirrhosis. In Journal of Hepatology (vol. 75, pp. s314-s314). Elsevier, Radarweg 29, 1043 Nx Amsterdam, Netherlands"},{"issue":"7","key":"6855_CR83","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1001\/jamapsychiatry.2022.1240","volume":"79","author":"N Vafaie","year":"2022","unstructured":"Vafaie N, Kober H (2022) Association of drug cues and craving with drug use and relapse: a systematic review and meta-analysis. JAMA Psychiatry 79(7):641\u2013650","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"6855_CR84","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/npp.2011.251","volume":"37","author":"S Vinogradov","year":"2012","unstructured":"Vinogradov S, Fisher M, de Villers-Sidani E (2012) Cognitive training for impaired neural systems in neuropsychiatric illness. Neuropsychopharmacology 37(1):43\u201376","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"6855_CR85","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1037\/h0027806","volume":"33","author":"D Watson","year":"1969","unstructured":"Watson D, Friend R (1969) Measurement of social-evaluative anxiety. J Consult Clin Psychol 33(4):448","journal-title":"J Consult Clin Psychol"},{"issue":"2","key":"6855_CR86","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40263-016-0403-y","volume":"31","author":"SJ Weintraub","year":"2017","unstructured":"Weintraub SJ (2017) Diazepam in the treatment of moderate to severe alcohol withdrawal. CNS Drugs 31(2):87\u201395","journal-title":"CNS Drugs"},{"key":"6855_CR87","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1037\/1064-1297.11.3.210","volume":"11","author":"SP Whiteside","year":"2003","unstructured":"Whiteside SP, Lynam DR (2003) Understanding the role of impulsivity and externalizing psychopathology in alcohol abuse: application of the UPPS impulsive behavior scale. Exp Clin Psychopharmacol 11:210\u2013217","journal-title":"Exp Clin Psychopharmacol"},{"issue":"4","key":"6855_CR88","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/0956797611400615","volume":"22","author":"RW Wiers","year":"2011","unstructured":"Wiers RW, Eberl C, Rinck M, Becker ES, Lindenmeyer J (2011) Retraining automatic action tendencies changes alcoholic patients\u2019 approach bias for alcohol and improves treatment outcome. Psychol Sci 22(4):490\u2013497","journal-title":"Psychol Sci"},{"issue":"4","key":"6855_CR89","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1176\/appi.ajp.2014.13111495","volume":"172","author":"CE Wiers","year":"2015","unstructured":"Wiers CE, Stelzel C, Gladwin TE, Park SQ, Pawelczack S, Gawron CK, Bermpohl F (2015) Effects of cognitive bias modification training on neural alcohol cue reactivity in alcohol dependence. Am J Psychiatry 172(4):335\u2013343","journal-title":"Am J Psychiatry"},{"key":"6855_CR90","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1007\/s00213-015-4027-6","volume":"232","author":"J Witteman","year":"2015","unstructured":"Witteman J, Post H, Tarvainen M, de Bruijn A, Perna EDSF, Ramaekers JG, Wiers RW (2015) Cue reactivity and its relation to craving and relapse in alcohol dependence: a combined laboratory and field study. Psychopharmacology 232:3685\u20133696","journal-title":"Psychopharmacology"},{"issue":"14","key":"6855_CR91","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1523\/JNEUROSCI.4977-13.2014","volume":"34","author":"KA Young","year":"2014","unstructured":"Young KA, Franklin TR, Roberts DC, Jagannathan K, Suh JJ, Wetherill RR, Childress AR (2014) Nipping cue reactivity in the bud: Baclofen prevents limbic activation elicited by subliminal drug cues. J Neurosci 34(14):5038\u20135043","journal-title":"J Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06855-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-025-06855-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06855-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T10:02:54Z","timestamp":1770372174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-025-06855-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6855"],"URL":"https:\/\/doi.org\/10.1007\/s00213-025-06855-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received approval from the Brugmann Hospital ethics committee (CE 2012\/94).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No relevant conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Subscription publishing model.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"All the participants provided their informed written consent in accordance with the declaration of Helsinki.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}